The companies are working together to make it easier for companies to offer health plans that include these medications.

A study by GNC suggests that GLP-1s users are risking malnourishment and muscle loss. GNC announced the results of a study ...

With acquisition of Verve Therapeutics, Eli Lilly aims to advance next-generation cardiovascular care through one-time gene ...

Andembry is the first prophylactic therapy for hereditary angioedema to target factor XIIa, inhibiting the top of the ...

Transformation in healthcare is ongoing and purpose-driven. It’s not a fleeting trend but a continuous process rooted in ...

While drug discount programs are potentially beneficial in increasing access to necessary medications, in some situations, ...

Recently, Vermont senator Bernie Sanders and Maine senator Angus King introduced a bill to ban prescription drug advertising ...

Starting July 7, 2025, the two highest doses of Zepbound will be available for a flat price of $499 per month, with shipments ...

Strategic actions by Supernus, Teva, Incyte, and BioNTech highlight growing momentum in advancing clinical-stage therapies ...

Under terms of the deal, CSPC will receive $110 million upfront, with potential milestone payments reaching up to $5.22 ...

Viseven announced a new AI agent for its content creation platform eWizard. The new agent, called eVa, is able to communicate ...

The company focuses on specialty drugs and uses a combination of AI and human expertise to automate the process.